Epacadostat: Enhancing Cancer Immunotherapy with IDO1 Inhibition
Unlock the power of your immune system against cancer. Discover the potential of this potent IDO1 inhibitor.
Get a Quote & SampleProduct Core Value
![N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboxamid](https://www.nbinno.com/2025/webimg/gemini_688d8106ec882_1754104070.png)
N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboxamidine
Epacadostat is a leading IDO1 inhibitor for cancer immunotherapy, designed to restore and amplify the body's natural immune defenses against malignant cells. Its selective action on IDO1 modulates the tumor microenvironment, offering a promising avenue for improved treatment outcomes.
- Discover the benefits of a potent IDO1 inhibitor for cancer immunotherapy, offering a novel approach to combatting various cancers by boosting immune surveillance.
- Learn about the epacadostat mechanism of action, where it selectively inhibits IDO1 to prevent tryptophan degradation and reduce immunosuppressive metabolites.
- Explore the significance of epacadostat in clinical trials, showcasing its potential in combination therapies and its impact on patient outcomes.
- Understand the advantages of an oral IDO1 inhibitor for immune response enhancement, providing a convenient and effective treatment modality.
Key Advantages
Enhanced Immune Activation
By targeting IDO1, Epacadostat promotes the proliferation and activation of key immune cells, including T-cells and NK cells, critical for fighting cancer. This is a key aspect of IDO1 selective inhibitor benefits.
Optimized Tumor Microenvironment
The inhibition of IDO1 activity by Epacadostat helps to reverse the immunosuppressive conditions within the tumor microenvironment, making it more conducive to immune attack. This is a crucial factor in advanced cancer immunotherapy strategies.
Synergistic Therapeutic Potential
Epacadostat demonstrates significant promise when used in conjunction with other immuno-oncology agents, such as checkpoint inhibitors, amplifying the overall anti-cancer effect and improving patient responses. This highlights its role in novel immuno-oncology targets.
Key Applications
Cancer Immunotherapy
Epacadostat is investigated for its role in boosting the immune system's ability to fight cancer, often in combination with other therapies. This aligns with its function as an IDO1 inhibitor for cancer immunotherapy.
Immuno-oncology
As a potent IDO1 inhibitor, it is central to immuno-oncology research, aiming to reactivate suppressed immune responses against tumors. Its development supports drug development for immunomodulation.
Tumor Microenvironment Modulation
By influencing tryptophan metabolism, Epacadostat modifies the tumor microenvironment to be less hospitable to cancer cell evasion, a key strategy in small molecule cancer therapeutics.
Immune Response Enhancement
The compound's mechanism of action directly enhances immune cell activity, contributing to a more robust anti-tumor immune response, which is a core focus in research chemicals for oncology.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).